Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Devices

IRIX:US

10.3600 USD 0.3400 3.39%

As of 20:10:00 ET on 04/27/2015.

Snapshot for IRIDEX Corp (IRIX)

Open: 11.0700 Day's Range: 10.0710 - 11.0935 Volume: 54,039
Previous Close: 10.0200 52wk Range: 6.4100 - 11.2765 1-Yr Rtn: +25.58%

Stock Chart for IRIX

No chart data available.
  • IRIX:US 10.3600
  • 1D
  • 1M
  • 1Y
10.0200
Interactive IRIX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IRIX

Current P/E Ratio (ttm) 10.4646
Estimated P/E(12/2015) -
Relative P/E vs. SPX 0.5622
Earnings Per Share (USD) (ttm) 0.9900
Est. EPS (USD) (12/2015) -
Est. PEG Ratio -
Market Cap (M USD) 102.14
Shares Outstanding (M) 9.86
30 Day Average Volume 21,374
Price/Book (mrq) 3.0054
Price/Sale (ttm) 2.3931
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/01/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IRIX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IRIX

IRIDEX Corporation provides semiconductor-based laser systems used to treat eye disease and skin lesions. The Company's products are sold around the world. IRIDEX markets its IRIS Medical products to the ophthalmic market, IRIDERM to the dermatological market, and Light Solutions to the research market.

William M MooreChairman/Interim Pres & CEOJames H MackanessCFO/COO
Ronald T SteckelVP:Operations
More Company Profile & Key Executives for IRIX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil